376 related articles for article (PubMed ID: 27783546)
1. Risk of Nondherence to Diabetes Medications Among Medicare Advantage Enrollees: Development of a Validated Risk Prediction Tool.
Mhatre SK; Serna O; Sansgiry S; Fleming ML; Essien EJ; Sansgiry SS
J Manag Care Spec Pharm; 2016 Nov; 22(11):1293-1301. PubMed ID: 27783546
[TBL] [Abstract][Full Text] [Related]
2. A Multichannel Medication Adherence Intervention Influences Patient and Prescriber Behavior.
Leslie RS; Gilmer T; Natarajan L; Hovell M
J Manag Care Spec Pharm; 2016 May; 22(5):526-38. PubMed ID: 27123914
[TBL] [Abstract][Full Text] [Related]
3. Predictors of Nonadherence to Topical Intraocular Pressure Reduction Medications Among Medicare Members: A Claims-Based Retrospective Cohort Study.
Sheer R; Bunniran S; Uribe C; Fiscella RG; Patel VD; Chandwani HS
J Manag Care Spec Pharm; 2016 Jul; 22(7):808-817a. PubMed ID: 27348282
[TBL] [Abstract][Full Text] [Related]
4. The Influence of a Community Pharmacy Automatic Prescription Refill Program on Medicare Part D Adherence Metrics.
Lester CA; Mott DA; Chui MA
J Manag Care Spec Pharm; 2016 Jul; 22(7):801-7. PubMed ID: 27348281
[TBL] [Abstract][Full Text] [Related]
5. Disparities in Initial Oral Antidiabetic Medication Adherence Among Veterans with Incident Diabetes.
Gatwood JD; Chisholm-Burns M; Davis R; Thomas F; Potukuchi P; Hung A; Kovesdy CP
J Manag Care Spec Pharm; 2018 Apr; 24(4):379-389. PubMed ID: 29578849
[TBL] [Abstract][Full Text] [Related]
6. Predictors of Change in Adherence Status from 1 Year to the Next Among Patients with Type 2 Diabetes Mellitus on Oral Antidiabetes Drugs.
Saundankar V; Peng X; Fu H; Ascher-Svanum H; Rodriguez A; Ali A; Slabaugh L; Young P; Louder A
J Manag Care Spec Pharm; 2016 May; 22(5):467-82. PubMed ID: 27123910
[TBL] [Abstract][Full Text] [Related]
7. Effect of Medicaid Policy Changes on Medication Adherence: Differences by Baseline Adherence.
Amin K; Farley JF; Maciejewski ML; Domino ME
J Manag Care Spec Pharm; 2017 Mar; 23(3):337-345. PubMed ID: 28230447
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of an integrated adherence program aimed to increase Medicare Part D star rating measures.
Leslie RS; Tirado B; Patel BV; Rein PJ
J Manag Care Spec Pharm; 2014 Dec; 20(12):1193-203. PubMed ID: 25443513
[TBL] [Abstract][Full Text] [Related]
9. The Effect of Opioid Use and Mental Illness on Chronic Disease Medication Adherence in Superutilizers.
Surbhi S; Graetz I; Wan JY; Gatwood J; Bailey JE
J Manag Care Spec Pharm; 2018 Mar; 24(3):198-207. PubMed ID: 29485952
[TBL] [Abstract][Full Text] [Related]
10. Is the Currently Used Prescription Adjudication Date a Good Proxy for Calculating Medication Refill Adherence?
Lester CA; Look KA; Chui MA
J Manag Care Spec Pharm; 2016 Nov; 22(11):1311-1317. PubMed ID: 27783554
[TBL] [Abstract][Full Text] [Related]
11. Impact of a Combined Value-Based Insurance Design and Medication Therapy Management Program on Diabetes Medication Adherence.
Peaslee A; Wickizer M; Olson J; Topp R
J Manag Care Spec Pharm; 2016 Nov; 22(11):1303-1309. PubMed ID: 27783550
[TBL] [Abstract][Full Text] [Related]
12. Medication Nonadherence Among Medicare Beneficiaries with Comorbid Chronic Conditions: Influence of Pharmacy Dispensing Channel.
Iyengar RN; LeFrancois AL; Henderson RR; Rabbitt RM
J Manag Care Spec Pharm; 2016 May; 22(5):550-60. PubMed ID: 27123916
[TBL] [Abstract][Full Text] [Related]
13. A Motivational Interviewing Intervention by Pharmacy Students to Improve Medication Adherence.
Abughosh S; Wang X; Serna O; Esse T; Mann A; Masilamani S; Holstad MM; Essien EJ; Fleming M
J Manag Care Spec Pharm; 2017 May; 23(5):549-560. PubMed ID: 28448784
[TBL] [Abstract][Full Text] [Related]
14. Impact of Environmental Factors on Differences in Quality of Medication Use: An Insight for the Medicare Star Rating System.
Desai V; Nau D; Conklin M; Heaton PC
J Manag Care Spec Pharm; 2016 Jul; 22(7):779-86. PubMed ID: 27348278
[TBL] [Abstract][Full Text] [Related]
15. Is There a Relationship Between Part D Medication Adherence and Part C Intermediate Outcomes Star Ratings Measures?
Ta JT; Erickson SC; Qiu WA; Patel BV
J Manag Care Spec Pharm; 2016 Jul; 22(7):787-95. PubMed ID: 27348279
[TBL] [Abstract][Full Text] [Related]
16. Adherence, Persistence, and Health Care Costs for Patients Receiving Dipeptidyl Peptidase-4 Inhibitors.
Rascati KL; Worley K; Meah Y; Everhart D
J Manag Care Spec Pharm; 2017 Mar; 23(3):299-306. PubMed ID: 28230454
[TBL] [Abstract][Full Text] [Related]
17. Improving Comprehensive Medication Review Acceptance by Using a Standardized Recruitment Script: A Randomized Control Trial.
Miguel A; Hall A; Liu W; Garrett J; Ballew A; Yang TH; Segal R
J Manag Care Spec Pharm; 2017 Jan; 23(1):13-21. PubMed ID: 28025924
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of Comprehensive Medication Review Completion Rates Using 3 Patient Outreach Models.
Miller DE; Roane TE; Salo JA; Hardin HC
J Manag Care Spec Pharm; 2016 Jul; 22(7):796-800. PubMed ID: 27348280
[TBL] [Abstract][Full Text] [Related]
19. Descriptive analysis of mail interventions with physicians and patients to improve adherence with antihypertensive and antidiabetic medications in a mixed-model managed care organization of commercial and Medicare members.
Jing S; Naliboff A; Kaufman MB; Choy M
J Manag Care Pharm; 2011 Jun; 17(5):355-66. PubMed ID: 21657805
[TBL] [Abstract][Full Text] [Related]
20. Risk for Medication Nonadherence Among Medicaid Enrollees With Fibromyalgia: Development of a Validated Risk Prediction Tool.
Desai R; Jo A; Marlow NM
Pain Pract; 2019 Mar; 19(3):295-302. PubMed ID: 30369018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
